Open AccessHMGB1 release by C5a anaphylatoxin is an effective target for sepsis treatment
Author(s) -
Hidechika Okada,
Noriko Okada,
Masaki Imai,
Akio Okada,
Fumiko Ono
Publication year - 2011
Publication title -
nature precedings
Language(s) - English
Resource type - Journals
ISSN - 1756-0357
DOI - 10.1038/npre.2011.5727.1
Subject(s) - hmgb1 , c5a receptor , endogeny , pharmacology , tlr4 , chemistry , antibody , stimulation , anaphylatoxin , peptide , sepsis , complement system , receptor , medicine , immunology , biochemistry